Longevity & Cellular Health Research Peptides

The short version

VitaPro Peptides is a reading desk, not a store. It collects what the published research literature actually says about two molecules that appear repeatedly in conversations about longevity and cellular health: MOTS-c and NAD+. One is a peptide — a very short chain of amino acids, the same building blocks that make up proteins — and the other is a coenzyme, a small molecule the cell uses as a sort of rechargeable battery. What they share is a deep connection to the mitochondrion, the organelle that powers every cell in your body.

This guide does one job: it tells you, in plain language and with citations, what each compound was tested on, in which species, and how far that evidence really reaches. Some of the NAD+ story involves human trials; most of the MOTS-c story does not. Neither is presented here with a dose recommendation. We do not sell anything and we do not give medical advice.

What are research peptides?

Proteins in your body — an enzyme that catalyzes a reaction, a structural fiber in muscle, a hormone that travels in the blood — are long chains of amino acids folded into precise shapes. A peptide is a much shorter chain of the same building blocks, sometimes only a handful of links long. Because they are small and structurally specific, peptides can act like molecular keys that fit particular locks (receptors or enzyme sites) on the surface of cells, switching programs on or off.

A research peptide is one that has been synthesized and studied in the laboratory — in cell cultures, in animals, occasionally in early human work — but has not been approved by a regulator as a medicine. Sellers describe such compounds as being for laboratory research only. That framing matters: it means that dosing, long-term safety, and real-world effectiveness in humans are usually unestablished. When this site reports a number, it reports it as the study reported it — for example, studied at 5 mg/kg in mice — never as a recommendation.

How these two fit into longevity research

The two compounds on this desk approach cellular aging from different angles, which is exactly why they sit together.

• MOTS-c is the lead. It is a 16-amino-acid peptide encoded not in the nuclear genome — where virtually all human genes live — but inside the mitochondrial genome itself. Under metabolic stress it travels from the mitochondrion to the nucleus and shifts gene expression, and it activates AMPK, the master energy-sensing kinase, by disrupting a specific metabolic shortcut ^[6]. In aged mice, exogenous MOTS-c significantly improved physical performance ^[4]; in a human observational cohort, circulating MOTS-c levels independently predicted cardiovascular and mortality outcomes ^[2].
• NAD+ is the cell's workhorse redox carrier — it picks up electrons from fuel burning and delivers them to the machinery that makes ATP — and it also feeds the signaling enzymes (sirtuins, PARPs, CD38) that govern DNA repair and gene regulation. Tissue NAD+ declines reliably with age, which is the central rationale for the supplement and IV-therapy market that has grown around precursors such as NMN and NR ^[11]. Human trials have shown that oral precursors reliably raise blood NAD+; translation to hard clinical endpoints is less consistent ^[8].

Together they frame the longevity question from two sides: a mitochondrially-encoded signal that modulates how the cell spends its energy, and the energy currency itself. Use the directory to read each one, or compare these peptides side by side.

A note on how this desk reads the literature

VitaPro Peptides is a cross-referenced literature digest. Each compound page summarizes the peer-reviewed studies for that molecule, cites them by number, and links to a single shared references list that aggregates every source. Where the evidence is thin, single-lab, or preclinical, we say so plainly — that caution is part of the record, not a footnote. We describe research findings and the cited cautions that come with them; we do not recommend, prescribe, or sell. The aim is a quiet, accurate map of what is known — so you can see where the science is solid and where it is still mostly promise.